1. Home
  2. GRNQ vs PLUR Comparison

GRNQ vs PLUR Comparison

Compare GRNQ & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

N/A

Current Price

$7.10

Market Cap

12.9M

Sector

Technology

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$1.24

Market Cap

12.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRNQ
PLUR
Founded
2013
2001
Country
Malaysia
Israel
Employees
41
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
12.5M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
GRNQ
PLUR
Price
$7.10
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.8K
★ 59.5K
Earning Date
11-20-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.46
EPS
★ N/A
N/A
Revenue
★ $3,673,997.00
$1,016,000.00
Revenue This Year
N/A
$902.46
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 24.55
N/A
52 Week Low
$1.12
$0.85
52 Week High
$318.00
$4.87

Technical Indicators

Market Signals
Indicator
GRNQ
PLUR
Relative Strength Index (RSI) 43.10 56.56
Support Level $6.34 $0.88
Resistance Level $12.05 $1.43
Average True Range (ATR) 0.63 0.15
MACD 0.20 0.03
Stochastic Oscillator 61.81 59.26

Price Performance

Historical Comparison
GRNQ
PLUR

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China, and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust, & wealth management. Its segments include the Service business engaged in the provision of corporate advisory & business solution services; the Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong & Malaysia; & the Digital business segment engaged in the provision of digital platform & trading of digital assets.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: